Nutex Health Future Growth
Future criteria checks 4/6
Nutex Health is forecast to grow earnings and revenue by 126% and 14.3% per annum respectively while EPS is expected to grow by 125.9% per annum.
Key information
126.0%
Earnings growth rate
125.9%
EPS growth rate
| Healthcare earnings growth | 20.8% |
| Revenue growth rate | 14.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 12 Nov 2024 |
Recent future growth updates
Recent updates
Health Check: How Prudently Does Nutex Health (NASDAQ:NUTX) Use Debt?
Jan 24
Nutex Health Inc. (NASDAQ:NUTX) Might Not Be As Mispriced As It Looks
Dec 25Nutex Health Inc. (NASDAQ:NUTX) Just Reported, And Analysts Assigned A US$2.75 Price Target
Aug 12Nutex Health Inc.'s (NASDAQ:NUTX) 30% Cheaper Price Remains In Tune With Revenues
Apr 17Nutex Health GAAP EPS of -$0.03, revenue of $58.05M
Aug 23Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 399 | 23 | N/A | N/A | 1 |
| 12/31/2025 | 352 | 10 | N/A | 35 | 2 |
| 12/31/2024 | 303 | -11 | N/A | 32 | 2 |
| 9/30/2024 | 292 | -41 | 20 | 21 | N/A |
| 6/30/2024 | 276 | -38 | 13 | 17 | N/A |
| 3/31/2024 | 259 | -41 | -3 | 3 | N/A |
| 12/31/2023 | 248 | -46 | -8 | 1 | N/A |
| 9/30/2023 | 232 | -29 | 5 | 8 | N/A |
| 6/30/2023 | 197 | -436 | -7 | -2 | N/A |
| 3/31/2023 | 196 | -451 | 6 | 16 | N/A |
| 12/31/2022 | 219 | -425 | 36 | 51 | N/A |
| 9/30/2022 | 229 | -396 | 58 | 93 | N/A |
| 6/30/2022 | 319 | 70 | 92 | 124 | N/A |
| 3/31/2022 | 336 | 122 | 123 | 158 | N/A |
| 12/31/2021 | 332 | 133 | 137 | 173 | N/A |
| 9/30/2021 | 374 | 159 | 94 | 160 | N/A |
| 12/31/2020 | 274 | 106 | 25 | 87 | N/A |
| 12/31/2019 | 97 | 21 | -20 | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NUTX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: NUTX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NUTX is expected to become profitable in the next 3 years.
Revenue vs Market: NUTX's revenue (14.3% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: NUTX's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NUTX's Return on Equity is forecast to be high in 3 years time